Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements with Trump

Wallstreetcn
2025.12.19 19:25
portai
I'm PortAI, I can summarize articles.

Nine pharmaceutical companies signed price agreements with Trump to avoid tariffs, including Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, and Sanofi. AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced agreements

Nine pharmaceutical companies signed a price agreement with Trump to avoid tariffs. These include Roche, Merck, Bristol Myers Squibb, GSK, Novartis, Gilead Sciences, Amgen, Sanofi, AbbVie, Johnson & Johnson, and Regeneron Pharmaceuticals have not yet announced an agreement with Trump.

Risk Warning and Disclaimer

The market has risks, and investment should be cautious. This article does not constitute personal investment advice and does not take into account the specific investment objectives, financial situation, or needs of individual users. Users should consider whether any opinions, views, or conclusions in this article are suitable for their specific circumstances. Investment based on this is at one's own risk

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.